a developer of novel gene therapies to treat patients with sight-threatening ophthalmic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with IMNM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then IMNM could also see price increases.
Ticker / NAME | Correlation To ADVM | 1D Price Change % | ||
---|---|---|---|---|
ADVM | 100% | -4.10% | ||
IMNM - ADVM | 38% Loosely correlated | -3.88% | ||
KPTI - ADVM | 31% Poorly correlated | -3.34% | ||
BTAI - ADVM | 31% Poorly correlated | -15.93% | ||
DNTH - ADVM | 25% Poorly correlated | -3.26% | ||
FDMT - ADVM | 24% Poorly correlated | +4.02% | ||
More |
Ticker / NAME | Correlation To ADVM | 1D Price Change % |
---|---|---|
ADVM | 100% | -4.10% |
gene therapy theme (12 stocks) | 25% Poorly correlated | -4.25% |
ophthalmology theme (7 stocks) | 17% Poorly correlated | -3.35% |
biotechnology theme (238 stocks) | 9% Poorly correlated | -1.76% |
surgery theme (21 stocks) | 4% Poorly correlated | -2.47% |